Stay updated on GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.

Latest updates to the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.6.6 is now shown on the page, indicating an updated release of the ClinicalTrials.gov interface; the change is a behind-the-scenes update to the site version rather than a change to the study information.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.6.5, signaling a new build/version of the site. This is a metadata update and does not alter the study details.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page now shows Revision: v3.6.4, indicating a minor update to the page's version tag. This is a metadata change that does not affect the displayed study information.SummaryDifference0.0%

- Check77 days agoChange DetectedA new Revision: v3.6.3 line was added and the previous Revision: v3.6.0 line removed, indicating a small update to the page version of the study record.SummaryDifference0.0%

- Check91 days agoChange DetectedNew help and navigation sections and contact information were added to guide users through eligibility and joining the study. The Intervention/Treatment heading was introduced/normalized and the older Intervention / Treatment heading was removed, with the revision stamp updated to v3.6.0.SummaryDifference0.4%

- Check98 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a new version of the page. This is an informational update and does not change the study content or on-page data.SummaryDifference0.0%

Stay in the know with updates to GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GS-1811 Study With Zimberelimab in Advanced Solid Tumors Clinical Trial page.